Neil W. Flanzraich

Neil W. Flanzraich is the current Chairman at Cantex Pharmaceuticals. Prior to their current position, they served as Chairman of the Life Sciences Legal Practice Group at Heller Ehrman from December 1994 to December 1997. Neil also has experience as Chairman of the Board at North American Vaccine, Inc. from December 1994 to December 1999, and as Senior Vice President, General Counsel and Member of the Operating and Executive Committees at Syntex Corporation from December 1980 to December 1993.

Neil W. Flanzraich has a Juris Doctorate from Harvard Law School and an A.B. from Harvard College. Neil was Phi Beta Kappa and Magna Cum Laude.